Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025Ophthalmology and TherapyOpen Access

Significant Correlation Between Choroidal Thickness and Decrease in Choroidal Blood Flow After Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAki Booka

Discussion

Loading...

Member takes

Overview

Analysis shows decreased choroidal blood flow associated with choroidal thickness in AMD, suggesting therapeutic implications of brolucizumab.

Key Points

  • Reduction in choroidal blood flow correlates with choroidal thickness changes after brolucizumab treatment.
  • Key metric: thicker choroidal tissue results in decreased blood flow following intervention.
  • Observational analysis of patients with refractory age-related macular degeneration treated with brolucizumab.
  • Findings underscore potential effects of medication on vascular health in age-related macular degeneration.

Cite This Study

Aki Booka (2025) studied this question.

synapsesocial.com/papers/6930dc92ea1aef094cca2957https://doi.org/10.1007/s40123-025-01279-9
View Full Paper
Ask AI
Bookmark
Share